Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07690605 · ClinicalTrials.gov registry record · NA
The Genomic and Well-Being Impacts of an Extraverted Behavior Intervention
A NA study, sponsored by University of California, Riverside.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT07690605: Completed NA study, sponsored by University of California, Riverside.
NCT07690605 is a NA study that has completed, run by University of California, Riverside. The registered enrollment target is 119 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07690605, a NA study, has completed, sponsored by University of California, Riverside.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
8-week randomized intervention (with 3-month follow-up) that examines the impact of increased sociable behavior on emotional well-being and immune health profile
Primary Outcome
Responses to loneliness sub-scale of Comprehensive Inventory of Thriving
Interventions
- BEHAVIORAL Sociable (extraverted) behavior
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2024-12-22 |
| Phase | NA |
What the finished NCT07690605 record still lists
NCT07690605 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Sociable (extraverted) behavior is the first listed.
NCT07690605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07690605 about?
NCT07690605 is a clinical study titled "The Genomic and Well-Being Impacts of an Extraverted Behavior Intervention". 8-week randomized intervention (with 3-month follow-up) that examines the impact of increased sociable behavior on emotional well-being and immune health profile
What is the current status of trial NCT07690605?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2024-03-08. Estimated completion is 2024-12-22.
What interventions are being tested in trial NCT07690605?
The interventions under investigation include: Sociable (extraverted) behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT07690605?
This trial is sponsored by University of California, Riverside, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07690605's enrollment target sits among peer trials
119 803rd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI